Tocladesine

DB13046InvestigationalSmall molecule

Tocladesine has been used in trials studying the treatment of Colorectal Cancer and Multiple Myeloma and Plasma Cell Neoplasm.

Chemical structure of Tocladesine
Formula / weight
C10H11ClN5O6P · 363.65 g/mol (avg)

Resolves to

Compound
UNIIBQ94Z7E5ORCAS41941-56-4ChEMBLCHEMBL2107085PubChem100299
Structure
InChIKeyCLLFEJLEDNXZNR-UUOKFMHZSA-NSMILESNC1=C2N=C(Cl)N([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1

What you can answer from here — as of February 21, 2021

39Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Tocladesine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In